Bone Fracture vs. the California Stem Cell Program: Disease-a-week Challenge #7Huffington PostAt the Cedars-Sinai Medical Center in Southern California, stem cell scientist Dan Gazit and orthopedic surgeon Hyun Bae are trying to do just that. Dr. Bae g… Continue reading
|
Stem cells solve multiple health problems
The Herald-News Ostir listed other health issues improved with amniotic stem cell treatment, including partial rotator cuff tears, tennis elbow, wrist and forearm tendonitis, and “Tommy John” injuries. “The phenomenal advances in regenerative medicine make it possible … |
|
Stem cells solve multiple health problems
The Herald-News Ostir listed other health issues improved with amniotic stem cell treatment, including partial rotator cuff tears, tennis elbow, wrist and forearm tendonitis, and “Tommy John” injuries. “The phenomenal advances in regenerative medicine make it possible … |
|
Pharma Leader Series: Top Stem Cell Technology Companies 2015-2025
MarketWatch Who are the top stem cell developers and producers? And what are their sales outlooks? Visiongain’s new report shows you their potentials from 2015. In this study, you will discover the therapies, results, trends in R&D, opportunities and revenue … |
The News-Press |
Stem cell treatment gives Estero woman hope, health
The News-Press So when she learned of an experimental protocol to bolster disease-fighting stem cells pioneered by hematologist/oncologist Dipnarine Maharaj at his South Florida Bone Marrow/Stem Cell Institute in Boynton Beach, she decided to go for it. “We had … |
The News-Press |
Stem cell treatment gives Estero woman hope, health
The News-Press So when she learned of an experimental protocol to bolster disease-fighting stem cells pioneered by hematologist/oncologist Dipnarine Maharaj at his South Florida Bone Marrow /Stem Cell Institute in Boynton Beach, she decided to go for it. “We had … |
|
New Studies & Research Evaluating Stem Cell Therapy Treatments for Bone …
PR Newswire (press release) Regen BioPharma, Inc. (OTC: RGBP) reported today the successful dosing of mice lacking an immune system in a safety and tolerability study with HemaXellerate, the Company’s proprietary aplastic anemia cell therapy drug candidate. The experiment is … Regen BioPharma, Inc. Reports Successful Dosing of HemaXellerate in FDA …CNNMoney |